We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Microgen | MCGN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 367.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 367.50 | 367.50 |
| Top Posts |
|---|
Posted at 31/8/2017 16:57 by shauney2 BusinesswireAug. 31, 2017, 04:00 AM Aptitude Software (Microgen plc) Acquires RevStream, Pioneering Enterprise Revenue Lifecycle Management Company, to Form the Global Market Leader in Revenue Recognition and Management Aptitude Software (Microgen plc), the fastest-rising financial software specialist, today announced the acquisition of RevStream, the market innovator in revenue accounting and management. Aptitude will add RevStream, the cloud-based, enterprise-grade ASC 606 and IFRS 15 revenue recognition solution to its portfolio of record-to-report specialist finance applications. The acquisition provides CFO’s with a partner that can address their many strategies and ambitions in an era when back-office ERP systems don’t support changing business models and the aspirations of financial executives. Over the last fifteen years, the monumental shift to new high-volume business models and forceful changes to accounting rules have impeded CFO’s who want to go beyond the traditional accounting role and deliver rapid, forward-looking information and insight into their businesses. Recent research reports show that CFO’s in all industries are affected. For example, the FSN Future of Finance Function Survey (2016 & 2017) found that 52% of finance teams spend too much time on manual transaction processing and 70% of organizations are yet to make headway in gaining ownership and control of all the data they need for effective business partnering. Accounting for a high-volume of complex products makes delivering financial transparency a weighty burden on finance teams who work nights and weekends to just deliver statutory reporting to stakeholders such as regulators, CEO’s and investors. Added to finance’s workload are new forceful accounting requirements brought on by the Enron scandal and 2008 financial crisis that have changed how companies must account for revenue, financial products and leases. In the case of revenue recognition, public companies must adopt new revenue recognition policies by 1 January 2018 – a change that has been described by one former CFO as the biggest change to accounting in over twenty years. Private companies must adopt these same accounting policies by the beginning of 2019. Unfortunately, with only months to go, only 13% of companies are more than 75% complete in the implementation of the new standard, as per a July 2017 survey from PWC. This means that over the next five years, In lieu of solutions such as those offered by Aptitude Software and RevStream, companies will face: Hugely increased manual workloads to deliver statutory reporting to regulators, investors and management Costly audits and potential litigation for companies that can’t provide evidence of compliance Reduced investment for those that can’t show comparability of earnings to new industry standards Since 2015 financial software specialist Aptitude Software has taken a leadership role in enabling telecommunications operators to address IFRS 15 and ASC 606 revenue recognition requirements. The company’s customer roster includes three of the four largest North American telco’s amongst numerous other leading global operators. When including RevStream, the combined company accounts for almost $1 trillion in revenue. The acquisition of RevStream extends Aptitude’s leadership in revenue recognition and adds to its North American presence (where 50% of Aptitude’s existing H1 2017 revenues derive). Importantly, the move gives Aptitude reach into technology, media and other sectors beyond its traditional footprint in financial services, insurance and telecoms. The RevStream acquisition extends Aptitude winning product portfolio which includes solutions spanning compliance (i.e. IFRS 9, 15, 16 and 17), operational accounting, enterprise revenue lifecycle management, financial data integration and financial calculations. The portfolio provides CFO’s with a clear path to enhance financial control, automation and insight. "Aptitude’s success has traditional come from our ability to help CFO’s rapidly process a very high volume of complex, business event-driven transactions and calculations” says Tom Crawford, Aptitude CEO. "With RevStream, we can offer a broader operational finance cloud platform for revenue management to mid- and large-sized companies at a time when new solutions are so desperately needed.” About Aptitude Software Aptitude Software delivers specialist financial applications to equip Chief Financial Officers (and the finance function) to fulfill their strategies and ambitions. Our software helps finance to supercharge control, reporting and analysis processes. What's the secret sauce? Well, we're finance experts who develop finance-centric solutions to control and automate complex accounting processes. This enables our customers to free time from traditional accounting roles and inject rich data & insights into their businesses. We deliver critical finance functionality to many of the world's biggest, most competitive companies. Aptitude Software is a Microgen plc company (LSE: MCGN). |
Posted at 18/11/2016 00:07 by tudes100 To MCGN Investor Relations....Morning, Could you confirm whether the company will be issuing a trading update before Christmas as in 2015 please ? "Thanks for your note. I am afraid we do not announce in advance the date of forthcoming trading updates, if any. Let me know if you have any other queries. Kind regards Phillip Wood |
Posted at 03/3/2015 11:48 by coul909 2blue - yes, I've made your point and mine to Investor Relations at MCGN, but as usual, they cannot say anything which is not in the public domain, i.e. RNS or the 'Circular' available on their website. I presume there may be some minor advantages for the company in tweaking the figures (such as EPS figures), and the cynical side of me assumes that they have already discussed this move with the major investors (funds etc). But for Private Investors at best it will be broadly neutral and for some (who now have an enforced tax situation in this financial year) they are likely to lose. I would be grateful to anyone with better knowledge of these company actions if they can explain how this action (which must be costing a few hundred thousand) could benefit the company or investors? thanks in advance. |
Posted at 05/2/2014 12:40 by jakedog2 Not boring me gleach :-)'Bowl' on the chart forming nicely. Tried ringing investor relations to get an exact date for results. No joy |
Posted at 07/6/2013 19:53 by checkers2 And here is the relevant extract from ft. Nothing new here just confermation of the view that this is a very low risk play, with reasonable upside potential.Because I'm battening down the hatches, I've been selling far more shares than I've been buying. But a notable exception was my recent purchase of shares in software supplier Microgen (MCG). The company had been on my watch list for some time. It is profitable, debt-free and pays dividends. But I held back from purchasing these shares because of the lack of profit growth. But an interesting development occurred about three weeks ago that prompted a change of heart. The company announced that its relatively small size was inhibiting growth. Many potential customers are large, risk-adverse companies who tend to favour Microgen's larger and more financially secure competitors. The company is considering several fresh strategic options. Its list includes the possibility of selling one or both of its two main divisions. My immediate reaction was that Microgen had put itself up for sale. Other investors apparently agreed with me because Microgen's shares bounced ahead by 9 per cent on the day. A second positive omen occurred two weeks later when heavy volume drove shares up by more than 7 per cent on a day when the FTSE 100 lost more than 100 points. Interest in this company is clearly growing. The graph provided another positive signal. Notice that the shares just burst through an area of resistance that had been in place for almost two years. I believe there is more upside to come despite underlying stock market conditions. |
Posted at 28/9/2011 09:27 by apad "Microgen is a UK-based, publicly listed company that also has offices in New York, Wroclaw, Hong Kong, Cape Town and the Cayman Islands. The odd one out amongst these cities is Wroclaw: hardly a hub of financial activity. The reason is that what has now become Aptitude (previously known as OST-Business Rules) was originally developed in Poland in the '90s as a rules engine that was first implemented by a leading bank. The technology was subsequently acquired by Microgen in 2002."This was interesting. I note that this comes from a sponsored article. Blindingly fast rule based systems seems a contradiction in terms. I guess the growth rate of Aptitude is the key metric W... As long as they are not booking sales in advance, which is a dreaded sleight of hand for software company investors. I gained some confidence when the company wanted to buy my shares. Currently checking out TRACSIS, which is a niche software company that has interesting characteristics. apad |
Posted at 04/6/2010 08:07 by darola From their website:Founded in early 2006, Highclere International Investors is a long-only international small and mid cap investment boutique with offices in London, UK and Connecticut. Our sole purpose is to invest client funds in small and mid-sized companies listed in markets outside North America. We focus on generating absolute returns for our clients over the long term, and are comfortable investing at the smaller, under-researched end of our universe. At Highclere we are very active in our investment analysis and travel the world seeking lesser known companies in which to invest. For more info: |
Posted at 03/6/2010 17:39 by truffle Feels as if it is set to go higher, particularly if overall market sentiment improves a bit.Recent director buying, and now an investor going over 3% is really encouraging. Who is/are Highclere? |
Posted at 17/2/2010 11:18 by rivaldo Perhaps more the case that investors realise the results are tomorrow and want to get in beforehand imo. |
Posted at 26/1/2010 07:23 by rivaldo Good to see you're so positive Truffle. It's just a question of patience, which has served investors here well to date.Positive stuff from Arbuthnot yesterday via UK-Analyst: "IT services firm Microgen (MCGN) was described by Arbuthnot as its "top pick" for the sector, having had a strong third quarter; the broker expects a good finish to the year. The disposal of the Billing Services division has allowed the company to focus on its Microgen Aptitude Solutions business, which provides data management. Microgen's Financial Systems business, though affected by the economic downturn, has a high level of recurring revenue. Arbuthnot said that it would "not be surprised" if some new contract wins were announced if the move out of recession continues. Increasing earnings, progressive expansion and new contract wins are expected to drive the company forward in 2010. The 'buy' stance and 100p target price was left unchanged. Microgen shares were unmoved at 89p." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
